查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413854

再生医学中的人工智慧市场：按技术、产品、应用和最终用户划分 - 2024-2030 年全球预测

Artificial Intelligence in Regenerative Medicine Market by Technology (Computer Vision, Context-Aware Computing, Machine Learning), Offering (Hardware, Services, Software), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年人工智慧再生医学市场规模为5,963万美元，2024年将达7,238万美元，2030年将达2,4063万美元，复合年增长率为22.05%。

再生医学人工智慧的全球市场

主要市场统计
基准年[2023] 5963万美元
预测年份 [2024] 7238万美元
预测年份 [2030] 2.4063亿美元
复合年增长率（%） 22.05%
人工智慧在再生医学市场-IMG1

人工智慧（AI）在再生医学中越来越重要，因为它是一种修復、替换和再生人体内受损或失去的组织和器官的多学科方法。人工智慧技术正在应用于再生医学的各个方面，以加速研究、加强患者照护并改善治疗结果。再生医学市场中的人工智慧包括将机器学习演算法、深度学习系统、自然语言处理工具和机器人等人工智慧技术整合到干细胞疗法、组织工程、免疫疗法和基因编辑技术中。公共和私营部门对研发活动的资金增加正在加速人工智慧等先进技术的采用。此外，癌症和心血管疾病等慢性疾病的盛行率不断上升，需要创新的治疗方法，而这些方法只能透过人工智慧驱动的再生医学提供的突破性解决方案来解决，需求不断增加，市场成长进一步加快。然而，用于训练人工智慧演算法的患者资讯的敏感性引发了资料隐私问题，而人工智慧系统使用的复杂演算法阻碍了市场的采用。个体化治疗的出现和次世代定序(NGS) 技术的进步正在产生大量需要先进分析技术的资料，为人工智慧在再生医学中的应用创造了新的机会。我是。

区域洞察

由于拥有大量投资、合作伙伴关係以及持续关注市场创新的主要市场参与者，美洲在再生医学人工智慧市场中占据关键地位。此外，政府的主导正在汇集各领域的研究人员，专注于整合人工智慧技术，开发器官再生和修復的新治疗方法。在欧盟 (EU)，地平线 2020 等资助计画正在分配大量资源来推进以人工智慧为基础的再生医学计划。政府推出了几个计划，使用机器学习演算法来绘製人类的每种细胞类型，进一步刺激了该地区的市场采用。在政府大量投资的支持下，亚太地区正在快速推动以人工智慧为基础的再生医学。主要公司正在建立专门的医疗保健部门，将人工智慧技术应用于医疗问题，包括再生疗法。政府也启动了战略倡议，开发再生医学人工智慧技术，以支持医疗保健和生物技术等产业，进一步加速该地区的市场采用。

FPNV定位矩阵

FPNV定位矩阵对于评估再生医学市场的人工智慧至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对再生医学市场人工智慧供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-再生医学人工智慧市场的市场规模和预测是多少？

2-在再生医学市场的人工智慧预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-再生医学人工智慧市场的技术趋势和法律规范是什么？

4-再生医学人工智慧市场主要厂商的市场占有率是多少？

5-进入再生医学人工智慧市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和罕见病患疾病率增加
      • 消费者对精准医疗和干细胞治疗的偏好日益增长
      • 政府支持将人工智慧引入医疗保健领域
    • 抑制因素
      • 基于人工智慧的再生医学解决方案相关的高成本
    • 机会
      • 改善药物研发与开发的技术进步
      • 增加人工智慧实施的资金和投资
    • 任务
      • 资料隐私问题和熟练专业人员的可用性有限
  • 市场区隔分析
    • 技术：大量采用电脑视觉技术，准确且有效率地侦测重要生物结构
    • 产品：硬体提供再生医学中人工智慧应用所需的运算能力。
    • 应用范例：在药物研发发现应用中利用 AL 技术的可能性
    • 最终用户：製药和生物技术公司专注于利用人工智慧加速药物研发
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章再生医学中的人工智慧市场：按技术划分

  • 电脑视觉
  • 情境感知计算
  • 机器学习
  • 自然语言处理

第七章再生医学中的人工智慧市场：透过提供

  • 硬体
    • 记忆
    • 通讯网路
    • 处理器
  • 服务
  • 软体

第八章再生医学中的人工智慧市场：按应用分类

  • 网路安全
  • 药物研发
  • 诈欺识别
  • 医疗保健支援机器人
  • 医疗图像与诊断
  • 患者资料和风险分析
  • 精准医疗

第九章再生医学中的人工智慧市场：按最终用户划分

  • 医疗保健付款人
  • 医院和医疗保健提供者
  • 製药和生物技术公司

第十章美洲再生医学人工智慧市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区再生医学人工智慧市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章：欧洲、中东和非洲再生医学领域的人工智慧市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析
    • 併购
    • 合约、合作和伙伴关係

第14章竞争产品组合

  • 主要公司简介
    • Cognetivity Ltd.
    • F. Hoffmann-La Roche Ltd.
    • Intel Corporation
    • Medtronic PLC
    • Merck KGaA
    • Microsoft Corporation
    • NANO-X IMAGING LTD.
    • Novo Nordisk A/S
    • NVIDIA Corporation
    • Sanofi SA
    • Tempus Labs, Inc.
    • Wipro Limited
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-A6768A62EE04

[196 Pages Report] The Artificial Intelligence in Regenerative Medicine Market size was estimated at USD 59.63 million in 2023 and expected to reach USD 72.38 million in 2024, at a CAGR 22.05% to reach USD 240.63 million by 2030.

Global Artificial Intelligence in Regenerative Medicine Market

KEY MARKET STATISTICS
Base Year [2023] USD 59.63 million
Estimated Year [2024] USD 72.38 million
Forecast Year [2030] USD 240.63 million
CAGR (%) 22.05%
Artificial Intelligence in Regenerative Medicine Market - IMG1

Artificial intelligence (AI) is increasingly important in regenerative medicine as it is a multidisciplinary approach to repairing, replacing, or regenerating damaged or lost tissues and organs within the human body. AI technologies are applied to various aspects of regenerative medicine to accelerate research, enhance patient care, and improve treatment outcomes. The AI in the regenerative medicine market encompasses integrating AI technologies such as machine learning algorithms, deep learning systems, natural language processing tools, and robotics with stem cell therapy, tissue engineering, immunotherapies, and gene editing techniques. Increased funding for research & development activities in both public and private sectors has accelerated the adoption of advanced technologies such as AI. Additionally, the rising prevalence of chronic conditions such as cancer and cardiovascular diseases has increased demand for innovative treatment approaches that can only be met through groundbreaking solutions provided by AI-enabled regenerative medicine, further increasing market growth. However, data privacy concerns arise due to the sensitive nature of patient information used for training AI algorithms, and the complex algorithms used by AI systems hamper market adoption. The advent of personalized therapy and advances in next-generation sequencing (NGS) technologies have generated vast amounts of data requiring sophisticated analysis methods; this poses yet another opportunity for AI's application within the regenerative medicine landscape.

Regional Insights

The Americas hold a significant landscape in the artificial intelligence in regenerative medicine market owing to significant investments and partnerships and the presence of key market players continuously focusing on innovations in the market. Additionally, the government initiative brings together researchers from various fields who focus on integrating AI technologies to develop novel therapeutic approaches for organ regeneration and repair. In the European Union, funding programs such as Horizon 2020 have allocated substantial resources to advance AI-based regenerative medicine projects. The government has launched several projects to map every human cell type using machine learning algorithms, further fueling the region's market adoption. APAC region is rapidly advancing in AI-based regenerative medicine, backed by significant government investments. Leading companies have established dedicated healthcare units that apply AI technologies to medical issues, including regenerative therapies. The government has also launched strategic initiatives to develop AI technologies for regenerative medicine to support industries such as healthcare and biotechnology, further fueling market adoption in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Artificial Intelligence in Regenerative Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Intelligence in Regenerative Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include Cognetivity Ltd., F. Hoffmann-La Roche Ltd., Intel Corporation, Medtronic PLC, Merck KGaA, Microsoft Corporation, NANO-X IMAGING LTD., Novo Nordisk A/S, NVIDIA Corporation, Sanofi SA, Tempus Labs, Inc., and Wipro Limited.

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Regenerative Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Computer Vision
    • Context-Aware Computing
    • Machine Learning
    • Natural Language Processing
  • Offering
    • Hardware
      • Memory
      • Network
      • Processor
    • Services
    • Software
  • Application
    • Cybersecurity
    • Drug Discovery
    • Fraud Detection
    • Healthcare Assistance Robots
    • Medical Imaging & Diagnostics
    • Patient Data & Risk Analysis
    • Precision Medicine
  • End-User
    • Healthcare Payers
    • Hospitals & Providers
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Artificial Intelligence in Regenerative Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Intelligence in Regenerative Medicine Market?

3. What are the technology trends and regulatory frameworks in the Artificial Intelligence in Regenerative Medicine Market?

4. What is the market share of the leading vendors in the Artificial Intelligence in Regenerative Medicine Market?

5. Which modes and strategic moves are suitable for entering the Artificial Intelligence in Regenerative Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Artificial Intelligence in Regenerative Medicine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic and rare diseases
      • 5.1.1.2. Growing consumer preference for precision medicines and stem cell therapies
      • 5.1.1.3. Supportive government initiatives for deployment of AI in healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with AI-based solutions for regenerative medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technologies for improved drug discovery and development
      • 5.1.3.2. Rising funding and investments for deployment of AI
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding data privacy coupled with limited availability of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Significant adoption of computer vision technology for accurate and efficient detection of key biological structures
    • 5.2.2. Offering: Hardware provides the necessary computational power in AI applications in regenerative medicine
    • 5.2.3. Application: Potential utilization of AL technology in drug discovery applications
    • 5.2.4. End-User: Pharmaceutical and biotechnology companies focus on leveraging AI to accelerate drug discovery
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Artificial Intelligence in Regenerative Medicine Market, by Technology

  • 6.1. Introduction
  • 6.2. Computer Vision
  • 6.3. Context-Aware Computing
  • 6.4. Machine Learning
  • 6.5. Natural Language Processing

7. Artificial Intelligence in Regenerative Medicine Market, by Offering

  • 7.1. Introduction
  • 7.2. Hardware
    • 7.3.1. Memory
    • 7.3.2. Network
    • 7.3.3. Processor
  • 7.3. Services
  • 7.4. Software

8. Artificial Intelligence in Regenerative Medicine Market, by Application

  • 8.1. Introduction
  • 8.2. Cybersecurity
  • 8.3. Drug Discovery
  • 8.4. Fraud Detection
  • 8.5. Healthcare Assistance Robots
  • 8.6. Medical Imaging & Diagnostics
  • 8.7. Patient Data & Risk Analysis
  • 8.8. Precision Medicine

9. Artificial Intelligence in Regenerative Medicine Market, by End-User

  • 9.1. Introduction
  • 9.2. Healthcare Payers
  • 9.3. Hospitals & Providers
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Artificial Intelligence in Regenerative Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Intelligence in Regenerative Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Regenerative Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Merger & Acquisition
      • 13.3.1.1. Axolotl Biologix and Carmell Therapeutics Enter Merger Deal
    • 13.3.2. Agreement, Collaboration, & Partnership
      • 13.3.2.1. Epredia and Aiforia Join RegenMed Hub Innovation Accelerator, Expanding PHC Group Presence in Regenerative Medicine Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program
      • 13.3.2.2. Wipro and Pandorum Partner to Accelerate Regenerative Medicine with Artificial Intelligence

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Cognetivity Ltd.
    • 14.1.2. F. Hoffmann-La Roche Ltd.
    • 14.1.3. Intel Corporation
    • 14.1.4. Medtronic PLC
    • 14.1.5. Merck KGaA
    • 14.1.6. Microsoft Corporation
    • 14.1.7. NANO-X IMAGING LTD.
    • 14.1.8. Novo Nordisk A/S
    • 14.1.9. NVIDIA Corporation
    • 14.1.10. Sanofi SA
    • 14.1.11. Tempus Labs, Inc.
    • 14.1.12. Wipro Limited
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET DYNAMICS
  • FIGURE 7. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 10. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 11. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 13. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MEMORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NETWORK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PROCESSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CYBERSECURITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FRAUD DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MEDICAL IMAGING & DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PATIENT DATA & RISK ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HOSPITALS & PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 240. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET LICENSE & PRICING